Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

AMPLICOR HIV-1 MONITOR granted U.S. approval

June 7, 1996

Diatide products in clinical trials: Techtide P280 and P748

June 7, 1996

CDR-grafted type III anti-CEA MAbs identified

June 7, 1996

Potential hypoxic marker synthesized by Evanston Hospital

May 31, 1996

Biomira seeks NDS approval in Canada for Tru-Scint AD

May 31, 1996

Resolution Pharm. enters research agreement

May 31, 1996

Immunoassays for free prostate-specific antigen covered under U.S. patent

May 31, 1996

Eagle Research to license Oral-Assist products

May 24, 1996

Orphan drug status for CEA-Scan

May 24, 1996

Peptide Therapeutics, Dr. Fooke to research arthritis diagnostics

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...